SUPERBRANCHE
Created in 2019
Trend leader (A+)
Existing signals make this entity one of the most dynamic startupsSocial networks
1,481Activities
Technologies
Entity types
Location
Institut de Science et d'Ingénierie Supramoléculaires, 8 All. Gaspard Monge 2, 67000 Strasbourg, France
Strasbourg
France
Employees
Scale: 2-10
Estimated: 10
Engaged catalyst
17
0 0Added in Motherbase
1 year, 8 months ago
Value proposition
Nanomaterials as Nanomedicines: let's play collective!
SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer
We bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand.
We position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size.
Our modular technology platform presents both therapeutic and diagnosis applications. It consists in a magnetic nanoparticle coated by a tailor made branched architecture.
Thanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously,
thus helping to the early detection and treatment of metastases.
The main advantage of the SUPERBRANCHE technology stem from
our specific processes and synthesis know-how which are at the heart of our innovations.
Superbranche is a Biotechnology company characterized by two main activities:
- the sale of dendrimers and nanoparticles as research products to any laboratory in the field of nanomedicine
- conducting development partnerships to bring to the clinics targeted diagnostic and image-guided therapy nanomaterials based on its proprietary technology.
Nanoparticles, Dendrimers, Theranostics, iv injectable nanomaterials, and RUO products for nanomedicineOriginal language
Nanomaterials as Nanomedicine: let's play collective!
SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer
We bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand.
We position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size.
Our modular technology platform presents both therapeutic and diagnosis applications. It consists in a magnetic nanoparticle coated by a tailor made branched architecture.
Thanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously,
thus helping to the early detection and treatment of metastases.
The main advantage of the SUPERBRANCHE technology stem from
our specific processes and synthesis know-how which are at the heart of our innovations.
Superbranche is a Biotechnology company characterized by two main activities:
- the sale of dendrimers and nanoparticles as research products to any laboratory in the field of nanomedicine
- conducting development partnerships to bring to the clinics targeted diagnostic and image-guided therapy nanomaterials based on its proprietary technology.
SuperBranche | Let's Play Collective ! Biotech Strasbourg
Superbranche, Des Nanoparticules qui révolutionnent le diagnostic / traitement des tumeurs cancéreuses et le suivi des thérapies cellulaires
https://www.superbranche.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 21 Feb 2024 | | |
 SEMIA Startup accelerator & VC, Business Consulting and Services | SEMIA Startup accelerator & VC, Business Consulting and Services | Other 7 Feb 2025 | | |
 BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 25 Feb 2025 | | |
 WiSEED Crowdfunding, Financial Services | WiSEED Crowdfunding, Financial Services | Other 28 Oct 2022 | | |
 Le Journal des Entreprises Media, Newspaper Publishing | Le Journal des Entreprises Media, Newspaper Publishing | Other 10 Mar 2023 | | |
 CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 29 Jun 2023 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 7 Feb 2025 | | |
 La French Tech Est Startup accelerator & VC, French Tech, Business Consulting and Services | La French Tech Est Startup accelerator & VC, French Tech, Business Consulting and Services | Other 6 Feb 2023 | | |